95 related articles for article (PubMed ID: 9310356)
1. Destabilization, oligomerization and inhibition of the mitogenic activity of acidic fibroblast-growth factor by aurintricarboxylic acid.
Lozano RM; Rivas G; Giménez-Gallego G
Eur J Biochem; 1997 Aug; 248(1):30-6. PubMed ID: 9310356
[TBL] [Abstract][Full Text] [Related]
2. Effect of low pH and heparin on the structure of acidic fibroblast growth factor.
Pineda-Lucena A; Núñez De Castro I; Lozano RM; Muñoz-Willery I; Zazo M; Giménez-Gallego G
Eur J Biochem; 1994 Jun; 222(2):425-31. PubMed ID: 7517355
[TBL] [Abstract][Full Text] [Related]
3. Introduction of a chemical constraint in a short peptide derived from human acidic fibroblast growth factor elicits mitogenic structural determinants.
Kiyota S; Franzoni L; Nicastro G; Benedetti A; Oyama S; Viviani W; Gambarini AG; Spisni A; Miranda MT
J Med Chem; 2003 Jun; 46(12):2325-33. PubMed ID: 12773037
[TBL] [Abstract][Full Text] [Related]
4. An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.
Alsenaidy MA; Wang T; Kim JH; Joshi SB; Lee J; Blaber M; Volkin DB; Middaugh CR
Protein Sci; 2012 Mar; 21(3):418-32. PubMed ID: 22113934
[TBL] [Abstract][Full Text] [Related]
5. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis.
Burgess WH; Shaheen AM; Hampton B; Donohue PJ; Winkles JA
J Cell Biochem; 1991 Feb; 45(2):131-8. PubMed ID: 1711526
[TBL] [Abstract][Full Text] [Related]
6. Deamidation of polyanion-stabilized acidic fibroblast growth factor.
Volkin DB; Verticelli AM; Bruner MW; Marfia KE; Tsai PK; Sardana MK; Middaugh CR
J Pharm Sci; 1995 Jan; 84(1):7-11. PubMed ID: 7536241
[TBL] [Abstract][Full Text] [Related]
7. The importance of Arg40 and 45 in the mitogenic activity and structural stability of basic fibroblast growth factor: effects of acidic amino acid substitutions.
Arakawa T; Holst P; Narhi LO; Philo JS; Wen J; Prestrelski SJ; Zhu X; Rees DC; Fox GM
J Protein Chem; 1995 Jul; 14(5):263-74. PubMed ID: 8590594
[TBL] [Abstract][Full Text] [Related]
8. 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor.
Lozano RM; Pineda-Lucena A; Gonzalez C; Angeles Jiménez M; Cuevas P; Redondo-Horcajo M; Sanz JM; Rico M; Giménez-Gallego G
Biochemistry; 2000 May; 39(17):4982-93. PubMed ID: 10819962
[TBL] [Abstract][Full Text] [Related]
9. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA
J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of recombinant human acidic fibroblast growth factor produced in E. coli: comparative studies with human basic fibroblast growth factor.
Watanabe T; Seno M; Sasada R; Igarashi K
Mol Endocrinol; 1990 Jun; 4(6):869-79. PubMed ID: 1700280
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the ability of several naturally occurring and synthetic polyanions to bind to and potentiate the biological activity of acidic fibroblast growth factor.
Belford DA; Hendry IA; Parish CR
J Cell Physiol; 1993 Oct; 157(1):184-9. PubMed ID: 7691835
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of the nuclear localization sequence in EGF-1 alters protein stability but not mitogenic activity.
Friedman S; Zhan X; Maciag T
Biochem Biophys Res Commun; 1994 Feb; 198(3):1203-8. PubMed ID: 7509598
[TBL] [Abstract][Full Text] [Related]
13. Structural modifications of acidic fibroblast growth factor alter activity, stability, and heparin dependence.
Thomas KA; Ortega S; Soderman D; Schaeffer MT; DiSalvo J; Gimenez-Gallego G; Linemeyer D; Kelly L; Menke J
Ann N Y Acad Sci; 1991; 638():9-17. PubMed ID: 1723866
[No Abstract] [Full Text] [Related]
14. Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate.
Fernández-Tornero C; Lozano RM; Redondo-Horcajo M; Gómez AM; López JC; Quesada E; Uriel C; Valverde S; Cuevas P; Romero A; Giménez-Gallego G
J Biol Chem; 2003 Jun; 278(24):21774-81. PubMed ID: 12676958
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas.
Lozano RM; Jiménez M; Santoro J; Rico M; Giménez-Gallego G
J Mol Biol; 1998 Sep; 281(5):899-915. PubMed ID: 9719643
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity.
Fu XB; Li XK; Wang T; Cheng B; Sheng ZY
World J Gastroenterol; 2004 Dec; 10(24):3590-6. PubMed ID: 15534912
[TBL] [Abstract][Full Text] [Related]
17. Effect of polyanions on the unfolding of acidic fibroblast growth factor.
Burke CJ; Volkin DB; Mach H; Middaugh CR
Biochemistry; 1993 Jun; 32(25):6419-26. PubMed ID: 7686045
[TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant human acidic fibroblast growth factor: comparative studies with bovine acidic fibroblast growth factor.
Xue Y; Wang H; Zhou T; Wang H; Wang F
Chin Med Sci J; 1993 Dec; 8(4):227-30. PubMed ID: 7518263
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic activity of peptides related to the sequence of human fibroblast growth factor-1.
Oyama S; Miranda MT; Toma IN; Viviani W; Gambarini AG
Biochem Mol Biol Int; 1996 Aug; 39(6):1237-44. PubMed ID: 8876978
[TBL] [Abstract][Full Text] [Related]
20. SHuffle™ T7 strain is capable of producing high amount of recombinant human fibroblast growth factor-1 (rhFGF-1) with proper physicochemical and biological properties.
Nasiri M; Babaie J; Amiri S; Azimi E; Shamshiri S; Khalaj V; Golkar M; Fard-Esfahani P
J Biotechnol; 2017 Oct; 259():30-38. PubMed ID: 28827102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
